| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 81321 |
|
1,861 |
1,784 |
$77K |
| 81317 |
|
728 |
681 |
$52K |
| 81298 |
|
730 |
681 |
$47K |
| 81249 |
|
838 |
814 |
$47K |
| 81223 |
|
745 |
726 |
$44K |
| 81311 |
|
1,088 |
1,036 |
$42K |
| 81302 |
|
100 |
77 |
$42K |
| 81238 |
|
919 |
912 |
$37K |
| 81292 |
|
169 |
124 |
$29K |
| 81410 |
|
67 |
57 |
$27K |
| 81307 |
|
808 |
802 |
$26K |
| 81275 |
|
186 |
150 |
$22K |
| 81324 |
|
351 |
346 |
$19K |
| 81162 |
|
33 |
17 |
$19K |
| 81345 |
|
1,340 |
1,305 |
$19K |
| 81175 |
|
405 |
400 |
$18K |
| 81309 |
|
564 |
541 |
$18K |
| 81295 |
|
167 |
124 |
$16K |
| 81210 |
|
954 |
931 |
$16K |
| 81351 |
|
87 |
85 |
$15K |
| 81161 |
|
67 |
57 |
$15K |
| 81191 |
|
1,698 |
1,675 |
$13K |
| 81407 |
|
18 |
13 |
$12K |
| 81320 |
|
1,378 |
1,341 |
$11K |
| 81185 |
|
39 |
38 |
$10K |
| 81236 |
|
405 |
400 |
$8K |
| 81333 |
|
784 |
755 |
$7K |
| 81256 |
|
594 |
544 |
$7K |
| 81194 |
|
41 |
39 |
$6K |
| 81192 |
|
554 |
550 |
$6K |
| 81334 |
|
889 |
889 |
$6K |
| 81232 |
|
395 |
393 |
$5K |
| 81271 |
|
485 |
480 |
$4K |
| 81171 |
|
405 |
400 |
$4K |
| 81224 |
|
26 |
26 |
$4K |
| 87483 |
|
2,024 |
1,723 |
$3K |
| 81279 |
|
830 |
830 |
$3K |
| 81233 |
|
883 |
883 |
$3K |
| 81305 |
|
830 |
830 |
$3K |
| 81216 |
|
785 |
785 |
$3K |
| 81335 |
|
819 |
818 |
$3K |
| 81400 |
|
89 |
57 |
$3K |
| 81327 |
|
691 |
691 |
$2K |
| 81330 |
|
48 |
34 |
$2K |
| 81339 |
|
1,189 |
1,188 |
$2K |
| 81332 |
|
48 |
34 |
$2K |
| 81291 |
|
298 |
292 |
$2K |
| 81243 |
|
388 |
383 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,795 |
2,103 |
$1K |
| 81251 |
|
351 |
346 |
$1K |
| 81250 |
|
1,109 |
1,109 |
$1K |
| 81241 |
|
392 |
392 |
$919.98 |
| 81260 |
|
1,116 |
1,116 |
$749.27 |
| 87631 |
|
2,170 |
1,811 |
$614.08 |
| 81312 |
|
507 |
502 |
$568.26 |
| 81242 |
|
678 |
678 |
$495.77 |
| 81209 |
|
679 |
679 |
$492.84 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,115 |
1,760 |
$375.52 |
| 87507 |
|
29 |
29 |
$370.47 |
| 87486 |
|
2,173 |
1,814 |
$259.27 |
| 87541 |
|
2,173 |
1,814 |
$259.27 |
| 87581 |
|
2,172 |
1,813 |
$259.27 |
| 87498 |
|
2,074 |
1,730 |
$258.27 |
| 87640 |
|
2,071 |
1,727 |
$258.27 |
| 81179 |
|
452 |
447 |
$217.00 |
| 81181 |
|
451 |
446 |
$217.00 |
| 81344 |
|
453 |
448 |
$217.00 |
| 81284 |
|
453 |
448 |
$217.00 |
| 81343 |
|
453 |
448 |
$217.00 |
| 81182 |
|
453 |
448 |
$217.00 |
| 81180 |
|
452 |
447 |
$217.00 |
| 81178 |
|
452 |
447 |
$217.00 |
| 81177 |
|
452 |
447 |
$217.00 |
| 81188 |
|
453 |
448 |
$217.00 |
| 81183 |
|
453 |
448 |
$217.00 |
| 81329 |
|
373 |
368 |
$217.00 |
| 81235 |
|
60 |
60 |
$178.20 |
| 87496 |
|
1,695 |
1,355 |
$92.64 |
| 81270 |
|
60 |
60 |
$65.64 |
| 87481 |
|
491 |
276 |
$56.14 |
| 87500 |
|
285 |
278 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,848 |
1,228 |
$0.00 |
| 81441 |
|
61 |
61 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
26 |
26 |
$0.00 |
| 81201 |
|
32 |
17 |
$0.00 |
| 81189 |
|
12 |
12 |
$0.00 |
| 87150 |
|
290 |
284 |
$0.00 |
| 81218 |
|
44 |
44 |
$0.00 |
| 87652 |
|
284 |
277 |
$0.00 |
| 81439 |
|
67 |
57 |
$0.00 |
| 87641 |
|
287 |
280 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
26 |
26 |
$0.00 |
| 81212 |
|
24 |
24 |
$0.00 |
| 81479 |
Unlisted molecular pathology procedure |
25 |
14 |
$0.00 |
| 81443 |
|
69 |
69 |
$0.00 |
| 81419 |
|
26 |
24 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
26 |
26 |
$0.00 |
| 81412 |
|
13 |
13 |
$0.00 |